ARDSLEY ADVISORY PARTNERS LP - 31 Dec 2025 SCHEDULE 13G/A Report for Aspire Biopharma Holdings Common Stock (ASBP)

Filing manager
ARDSLEY ADVISORY PARTNERS LP
Reporting owner
Ardsley Advisory Partners LP
Security
Aspire Biopharma Holdings Common Stock
Beneficially owned shares
0 shares
Ownership signal 1 fact
Class ownership
0%
Subject security 1 fact
Symbol
ASBP
SEC evidence 4 facts
Form type
SCHEDULE 13G/A
Accepted by SEC
13 May 2026, 13:00:34 UTC
Event date
31 Dec 2025
SEC filing
View on sec.gov

Key filing fact

ARDSLEY ADVISORY PARTNERS LP disclosed 0% ownership in Aspire Biopharma Holdings Common Stock (ASBP) on 31 Dec 2025.

Key facts

  • ARDSLEY ADVISORY PARTNERS LP filed SCHEDULE 13G/A for Aspire Biopharma Holdings Common Stock (ASBP).
  • Disclosed ownership: 0%.
  • Date of event: 31 Dec 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 13 May 2026, 13:00.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (6)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Ardsley Advisory Partners LP 0% 0 0 0 /s/ Steve Napoli Steve Napoli/ Member
Ardsley Advisory Partners GP LLC 0% 0 0 0 /s/ Steve Napoli Steve Napoli/ Member
Ardsley Partners I GP LLC 0% 0 0 0 /s/ Steve Napoli Steve Napoli/ Member
Ardsley Partners Advanced Healthcare Fund, L.P. 0% 0 0 0 /s/ Steve Napoli Steve Napoli/ Member
Ardsley Partners Fund II, L.P. 0% 0 0 0 /s/ Steve Napoli Steve Napoli/ Member
Philip J. Hempleman 0% 0 0 0 /s/ Steve Napoli* Steve Napoli/Attorney-in Fact for Philip J. Hempleman
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .